Current understanding and management of aggressive posterior retinopathy of prematurity

doi:10.5318/wjo.v5.i2.73

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6664)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

483

WORD

250

HTML

3957

Figures (1-3)

190

Sum=4880

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

769

Download

1015

Sum=1784

May 12, 2015 (publication date) through Apr 15, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Ophthalmology

ISSN

2218-6239

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Ophthalmol. May 12, 2015; 5(2): 73-79
Published online May 12, 2015. doi: 10.5318/wjo.v5.i2.73

Full Size Figure Download Figure

Figure 3 Fluorescein angiogram of the right eye reveals extensive areas of avascular retina. There is a well demarcated line of advancing vessels with areas of neovascularization present. The arrow depicts the original area of the stage 3 ridge in zone 1 at the time of bevacizumab injection.

Citation: Pulido CM, Quiram PA. Current understanding and management of aggressive posterior retinopathy of prematurity. World J Ophthalmol 2015; 5(2): 73-79
URL: https://www.wjgnet.com/2218-6239/full/v5/i2/73.htm
DOI: https://dx.doi.org/10.5318/wjo.v5.i2.73